Revisiting the Utility of Dilated Fundus Exams in Patients with Neovascular Age-Related Macular Degeneration Receiving Regular Intravitreal Injections

Fares Antaki,1,2 Daniel Milad,3 Ali Dirani4 1Department of Ophthalmology, Université de Montréal, Montreal, QC, Canada; 2Centre Universitaire d’Ophtalmologie (CUO), Hôpital Maisonneuve-Rosemont, CIUSSS de l’Est-De-l’île-De-Montr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Antaki F, Milad D, Dirani A
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/3d940494811d40a99b6c97c6d96c4393
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3d940494811d40a99b6c97c6d96c4393
record_format dspace
spelling oai:doaj.org-article:3d940494811d40a99b6c97c6d96c43932021-12-02T15:52:24ZRevisiting the Utility of Dilated Fundus Exams in Patients with Neovascular Age-Related Macular Degeneration Receiving Regular Intravitreal Injections1177-5483https://doaj.org/article/3d940494811d40a99b6c97c6d96c43932021-03-01T00:00:00Zhttps://www.dovepress.com/revisiting-the-utility-of-dilated-fundus-exams-in-patients-with-neovas-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Fares Antaki,1,2 Daniel Milad,3 Ali Dirani4 1Department of Ophthalmology, Université de Montréal, Montreal, QC, Canada; 2Centre Universitaire d’Ophtalmologie (CUO), Hôpital Maisonneuve-Rosemont, CIUSSS de l’Est-De-l’île-De-Montréal, Montreal, QC, Canada; 3Faculty of Medicine, Université Laval, Quebec City, QC, Canada; 4Department of Ophthalmology, Centre Universitaire d’Ophtalmologie, Hôpital du Saint-Sacrement, CHU de Québec - Université Laval, Quebec City, QC, CanadaCorrespondence: Ali DiraniDepartment of Ophthalmology, Centre Universitaire d’Ophtalmologie, Hôpital du Saint-Sacrement, CHU de Québec - Université Laval, Quebec City, QC, CanadaEmail drdirani@gmail.comAbstract: Patients receiving regular anti-vascular endothelial growth factor (anti-VEGF) intravitreal injections for neovascular age-related macular degeneration (nAMD) routinely undergo dilated fundus examination (DFE) at each visit. In this paper, we review the current evidence on the utility of DFE in guiding treatment of established patients with nAMD and discuss novel treatment algorithms that defer DFE assessments with the advent of optical coherence tomography (OCT). We also debate on the value of DFE in the current sanitary context of COVID-19 and highlight important clinical scenarios where it must be performed.Keywords: age-related macular degeneration, dilated fundus exam, intravitreal injections, COVID-19, optical coherence tomographyAntaki FMilad DDirani ADove Medical Pressarticleage-related macular degenerationdilated fundus examintravitreal injectionscovid-19optical coherence tomographyOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 15, Pp 1129-1131 (2021)
institution DOAJ
collection DOAJ
language EN
topic age-related macular degeneration
dilated fundus exam
intravitreal injections
covid-19
optical coherence tomography
Ophthalmology
RE1-994
spellingShingle age-related macular degeneration
dilated fundus exam
intravitreal injections
covid-19
optical coherence tomography
Ophthalmology
RE1-994
Antaki F
Milad D
Dirani A
Revisiting the Utility of Dilated Fundus Exams in Patients with Neovascular Age-Related Macular Degeneration Receiving Regular Intravitreal Injections
description Fares Antaki,1,2 Daniel Milad,3 Ali Dirani4 1Department of Ophthalmology, Université de Montréal, Montreal, QC, Canada; 2Centre Universitaire d’Ophtalmologie (CUO), Hôpital Maisonneuve-Rosemont, CIUSSS de l’Est-De-l’île-De-Montréal, Montreal, QC, Canada; 3Faculty of Medicine, Université Laval, Quebec City, QC, Canada; 4Department of Ophthalmology, Centre Universitaire d’Ophtalmologie, Hôpital du Saint-Sacrement, CHU de Québec - Université Laval, Quebec City, QC, CanadaCorrespondence: Ali DiraniDepartment of Ophthalmology, Centre Universitaire d’Ophtalmologie, Hôpital du Saint-Sacrement, CHU de Québec - Université Laval, Quebec City, QC, CanadaEmail drdirani@gmail.comAbstract: Patients receiving regular anti-vascular endothelial growth factor (anti-VEGF) intravitreal injections for neovascular age-related macular degeneration (nAMD) routinely undergo dilated fundus examination (DFE) at each visit. In this paper, we review the current evidence on the utility of DFE in guiding treatment of established patients with nAMD and discuss novel treatment algorithms that defer DFE assessments with the advent of optical coherence tomography (OCT). We also debate on the value of DFE in the current sanitary context of COVID-19 and highlight important clinical scenarios where it must be performed.Keywords: age-related macular degeneration, dilated fundus exam, intravitreal injections, COVID-19, optical coherence tomography
format article
author Antaki F
Milad D
Dirani A
author_facet Antaki F
Milad D
Dirani A
author_sort Antaki F
title Revisiting the Utility of Dilated Fundus Exams in Patients with Neovascular Age-Related Macular Degeneration Receiving Regular Intravitreal Injections
title_short Revisiting the Utility of Dilated Fundus Exams in Patients with Neovascular Age-Related Macular Degeneration Receiving Regular Intravitreal Injections
title_full Revisiting the Utility of Dilated Fundus Exams in Patients with Neovascular Age-Related Macular Degeneration Receiving Regular Intravitreal Injections
title_fullStr Revisiting the Utility of Dilated Fundus Exams in Patients with Neovascular Age-Related Macular Degeneration Receiving Regular Intravitreal Injections
title_full_unstemmed Revisiting the Utility of Dilated Fundus Exams in Patients with Neovascular Age-Related Macular Degeneration Receiving Regular Intravitreal Injections
title_sort revisiting the utility of dilated fundus exams in patients with neovascular age-related macular degeneration receiving regular intravitreal injections
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/3d940494811d40a99b6c97c6d96c4393
work_keys_str_mv AT antakif revisitingtheutilityofdilatedfundusexamsinpatientswithneovascularagerelatedmaculardegenerationreceivingregularintravitrealinjections
AT miladd revisitingtheutilityofdilatedfundusexamsinpatientswithneovascularagerelatedmaculardegenerationreceivingregularintravitrealinjections
AT dirania revisitingtheutilityofdilatedfundusexamsinpatientswithneovascularagerelatedmaculardegenerationreceivingregularintravitrealinjections
_version_ 1718385564699328512